(Q41429377)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

review article

1 reference

title

Other viral agents of perinatal importance. Varicella, parvovirus, respiratory syncytial virus, and enterovirus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

H L Keyserling

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 March 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

published in

Clinics in Perinatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

193-211

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

Profile of enterovirus disease in the first two weeks of life

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Diagnosis of neonatal enterovirus infection by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Viral pneumonia in the first month of life

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Neonatal enterovirus infection: virology, serology, and effects of intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

The association of apnea and respiratory syncytial virus infection in infants

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Protective and disease-enhancing immune responses to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Human parvovirus, the cause of erythema infectiosum (fifth disease)?

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Intrauterine parvovirus infection associated with hydrops fetalis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Respiratory syncytial virus in early infancy. Circulating antibody and the severity of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Respiratory syncytial virus-related apnea in infants. Demographics and outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Parvovirus-like particles in human sera

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Consequences of varicella and herpes zoster in pregnancy: prospective study of 1739 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Acyclovir therapy in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

High-dose, short-duration ribavirin aerosol therapy compared with standard ribavirin therapy in children with suspected respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Respiratory virus immunization. I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group, and maternal antibody level

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

The incidence of human parvovirus B19 infection during pregnancy and its impact on perinatal outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Use of intravenous gamma globulin to passively immunize high-risk children against respiratory syncytial virus: safety and pharmacokinetics. The RSVIG Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Prospects for a respiratory syncytial virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Neonatal respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Albuterol responsiveness in infants with respiratory failure caused by respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Epidemiology of neonatal enterovirus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

An association between fetal parvovirus B19 infection and fetal anomalies: a report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Multiple congenital defects following maternal varicella; report of a case

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Enterovirus infections in neonates

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Role of maternal antibody in pneumonia and bronchiolitis due to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Respiratory syncytial viral infection in infants with congenital heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Immunomodulating therapy in experimental myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Aerosolized ribavirin in mechanically ventilated children with respiratory syncytial virus lower respiratory tract disease: a prospective, double-blind, randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Controlled trial to evaluate protection of high-risk infants against respiratory syncytial virus disease by using standard intravenous immune globulin

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

A simultaneous outbreak of respiratory syncytial virus and parainfluenza virus type 3 in a newborn nursery

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Congenital varicella in term infants: risk reconsidered

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Enteroviral disease in early infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Recovery of cytopathogenic agent from chimpanzees with coryza

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Human parvovirus and the fetus

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Echovirus 11 infection and prophylactic antiserum

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Use of normal immunoglobulin in an echovirus 11 outbreak in a special-care baby unit

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Fatal echovirus 11 infections in outbreak in special-care baby unit

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Maternal antibody and respiratory syncytial virus infection in infancy

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Parvovirus infections and hypoplastic crisis in sickle-cell anaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Purified fusion protein vaccine protects against lower respiratory tract illness during respiratory syncytial virus season in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Dexamethasone in bronchiolitis: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Intrauterine viral infections

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Congenital malformations following chickenpox, measles, mumps, and hepatitis. Results of a cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

A controlled trial of aerosolized ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Use of intravenous immunoglobulin in twin neonates with disseminated coxsackie B1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Concurrent outbreaks of rhinovirus and respiratory syncytial virus in an intensive care nursery: Epidemiology and associated risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Antibodies to respiratory syncytial virus polypeptides and their significance in human infection

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Parvovirus B19 associated with fetal abnormality

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

Historical cohort evaluation of ribavirin efficacy in respiratory syncytial virus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0095-5108%2818%2930192-1

7 January 2021

10.1016/S0095-5108(18)30192-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9099510%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference